Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3577)
All Articles published online
|
Mar 15, 2012 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marignani M, Gigante E, Begini P, Marzano A, di Fonzo M, Deli I, Gallina S, Cox MC, Delle Fave G. Patients with hematological malignancies and serological signs of prior resolved hepatitis B. World J Gastrointest Oncol 2012; 4(3): 37-45 [PMID: 22468182 DOI: 10.4251/wjgo.v4.i3.37] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v4/i3/37.htm |
| Number | Citing Articles |
| 1 |
Alessandra Zannella, Massimo Marignani, Paola Begini. Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management. Viruses 2019; 11(9): 858 doi: 10.3390/v11090858
|
| 2 |
Michele Barone, Antonella Notarnicola, Giuseppe Lopalco, Maria Teresa Viggiani, Francesco Sebastiani, Michele Covelli, Florenzo Iannone, Alfonso W. Avolio, Alfredo Di Leo, Luca Cantarini, Giovanni Lapadula. Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection. Hepatology 2015; 62(1): 40 doi: 10.1002/hep.27716
|
| 3 |
Melissa Padovan, Matteo Filippini, Angela Tincani, Elisabetta Lanciano, Eleonora Bruschi, Oscar Epis, Pietro Garau, Alessandro Mathieu, Eleonora Celletti, Leopoldo Giani, Paola Tomietto, Fabiola Atzeni, Piercarlo Sarzi Puttini, Francesca Zuliani, Salvatore De Vita, Francesco Trotta, Anastasio Grilli, Massimo Puoti, Marcello Govoni. Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection. Arthritis Care & Research 2016; 68(6): 738 doi: 10.1002/acr.22786
|
| 4 |
Xiaoming Fei, Fang Lei, Haifeng Zhang, Hua Lu, Yan Zhu, Yu Tang. Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study. Supportive Care in Cancer 2016; 24(6): 2727 doi: 10.1007/s00520-016-3085-6
|
| 5 |
Luca Laurenti, Francesco Autore, Idanna Innocenti, Barbara Vannata, Nicola Piccirillo, Federica Sorà, Domenico Speziale, Maurizio Pompili, Dimitar Efremov, Simona Sica. Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. Leukemia & Lymphoma 2015; 56(10): 2841 doi: 10.3109/10428194.2015.1017822
|
| 6 |
Sung-Nan Pei, Chien-Hung Chen. Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab. Leukemia & Lymphoma 2015; 56(6): 1611 doi: 10.3109/10428194.2014.964699
|
| 7 |
M.I. Biondo, V. Germano, M. Pietrosanti, M. Canzoni, M. Marignani, T. Stroffolini, S. Salemi, R. D'Amelio. Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies. European Journal of Internal Medicine 2014; 25(5): 482 doi: 10.1016/j.ejim.2013.11.014
|